This study is currently not recruiting participants.

Safety and Efficacy of Concentrated Autologous Concentrated Bone Marrow Aspirate (cBMA) in Preventing Wound Complications in Below Knee Amputation (BKA) (The MarrowCHAMP Study)

Study on Investigational Treatment for Wound Complications after Below Knee Amputation

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to determine the safety and explore efficacy of cBMA in preventing wound complications in below knee amputation.

Detailed description of study

The purpose of this study is to determine the safety and explore efficacy of cBMA in preventing wound complications in below knee amputation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Below Knee Amputation
  • Age: 100 years or below
  • Gender: All

This study investigates the safety and effectiveness of an investigational treatment in preventing wound complications in patients who have undergone a below knee amputation. The study aims to understand how well this treatment works and if it is safe for patients.

Participants in this study will receive either the investigational treatment or a placebo. A placebo is an inactive substance that looks like the investigational treatment but does not contain any medicine. The study will monitor participants for any side effects and the occurrence of wound complications.

  • Who can participate: The study is open to individuals who have had a below knee amputation. Participants must meet specific health criteria to ensure safety during the trial. Age criteria also apply, and participants must be within the specified age range.
  • Study details: Participants will be assigned to receive either the investigational treatment or a placebo. A placebo is an inactive substance that looks like the investigational treatment but does not contain any medicine.
Updated on 19 Feb 2024. Study ID: 1511774456

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team